H&R Block (NYSE:HRB) reported a wider-than-expected loss for the second quarter of fiscal 2024, missing analysts' forecasts. The company's stock fell 2.49% in after-hours trading following the ...
Good day, everyone, and welcome to today's Neurocrine Biosciences reports Q4 and fiscal year 2024 Earnings Call. (Operator Instructions) Please note today's call will be recorded and I will be ...
As Lazarus Chakwera’s time in office draws to a close, it’s only fair that we evaluate him based on the promises he set for himself. In his own words, his 100-day plan was supposed to be the ...